Miso Robotics

Miso Robotics launched its next-generation Flippy fry station in January 2025, a complete redesign built on five years of proprietary deployment data and millions of fry baskets processed in real-world US fast-food kitchens (including White Castle and Jack in the Box), taking over the hazardous,…

Country: United States

fry-station-robot us

Coverage

	CN	EU	US
food-alt-protein	✓	✓	✓

Regulatorsfdaefsamoa-china

Verifiable facts

Fact	Value	Source
Funding	Miso has raised over $130 million from more than 40,000 individual investors through Regulation A+ and Regulation CF offerings, as well as venture funding and a strategic investment from Ecolab.	embodyvc.com · sec.gov
Production site	Final stage AI learning and fine-tuning are completed at Miso’s robotics laboratory in Los Angeles, CA. Flippy units are assembled using various third-party partners.	invest.misorobotics.com · sec.gov
Certification	Flippy has received certification by NSF International for meeting sanitation standards for commercial kitchen equipment and receives an NRTL approval to meet electrical safety standards.	sec.gov
Revenue	$514,798 for the year ended December 31, 2025.	sec.gov
Headcount	Approximately 43 full-time employees and two part-time employees as of early 2026, or 87 total employees per Revelio Labs as of March 2026.	sec.gov
Capacity	Miso has focused on scaling Flippy installations, with units processed in seven U.S. states and over 5 million baskets fried as of mid-2026. Exact unit deployment counts are not disclosed. medium confidence	embodyvc.com · sec.gov
Regulatory approval	Flippy receives NRTL approval to meet electrical safety standards. Federal regulations allow employees under 18 years of age to operate Flippy.	sec.gov

Independent sources: embodyvc.com · sec.gov

Technologies

Name	Cluster	Risk
3D food printing & kitchen robotics	food-alt-protein	Medium	→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.